Assessment of the Pharmacokinetics of BLU-5937 Extended Release Prototypes and a BLU-5937 Immediate Release Reference Formulation
Clinical trial NCT05570539 · COMPLETED
Trial details
- NCT number
- NCT05570539
- Sponsor
- Bellus Health Inc. - a GSK company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-07
- Primary completion
- 2024-05-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.